MCNAIR; LINDSAY

Patent Applications and Registrations

Patent applications and USPTO patent grants for MCNAIR; LINDSAY.The latest application filed is for "treatment of hepatitis c virus with telaprevir (vx-950) in patients non-responsive to treatment with pegylated interferon-alpha 2a/2b and ribavirin".

Company Profile

0.4.6

MCNAIR; LINDSAY - ALLSTON MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Hepatitis C Virus With Telaprevir (vx-950) In Patients Non-responsive To Treatment With Pegylated Interferon-alpha 2a/2b And Ribavirin App 20140127160 - MCNAIR; LINDSAY ; et al.	2014-05-08
Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin Grant 8,664,273 - McNair , et al. March 4, 2	2014-03-04
Dose forms Grant 8,431,615 - Chu , et al. April 30, 2	2013-04-30
Treatment Of Hepatitis C Virus With Telaprevir (vx-950) In Patients Non-responsive To Treatment With Pegylated Interferon-alpha 2a/2b And Ribavirin App 20120045415 - McNair; Lindsay ; et al.	2012-02-23
HCV Combination Therapies Comprising Pegylated Interferon, Ribavirin and Telaprevir App 20120039850 - McNair; Lindsay ; et al.	2012-02-16
HCV Combination Therapies App 20100226889 - McNair; Lindsay	2010-09-09
Dose forms comprising VX-950 and their dosage regimen App 20100189688 - McNair; Lindsay ; et al.	2010-07-29
Dose forms App 20060105978 - Chu; Hui-May ; et al.	2006-05-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.